secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001140361-24-034440
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics promotes Brad Tade to CFO and Treasurer, effective July 24, 2024
-------------------------------------------------------------------------------

- Brad Tade, former VP Financial Operations, promoted to CFO and Treasurer effective July 24, 2024.
- Base salary set at $435,000 annually; target bonus of 45% of base salary.
- Granted 115,100 stock options and 72,400 RSUs, each vesting over four years.
- Severance includes 12 months base salary; 15 months plus 1.5x target bonus if within one year of change of control.
- Tade joined ADMA in June 2023; prior roles at Baxter International and Becton Dickinson.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124034440/0001140361-24-034440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124034440/ef20033085_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-034440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer